SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism
M Packer - Nature Reviews Cardiology, 2023 - nature.com
Abstract Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce heart failure events by
direct action on the failing heart that is independent of changes in renal tubular function. In …
direct action on the failing heart that is independent of changes in renal tubular function. In …
Iron deficiency in heart failure: mechanisms and pathophysiology
RIS Alnuwaysir, MF Hoes, DJ van Veldhuisen… - Journal of clinical …, 2021 - mdpi.com
Iron is an essential micronutrient for a myriad of physiological processes in the body beyond
erythropoiesis. Iron deficiency (ID) is a common comorbidity in patients with heart failure …
erythropoiesis. Iron deficiency (ID) is a common comorbidity in patients with heart failure …
Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика …
ВЮ Мареев, ИВ Фомин, ФТ Агеев, ЮЛ Беграмбекова… - Кардиология, 2018 - lib.ossn.ru
1–«МНОЦ МГУ им. МВ Ломоносова», 119192, Москва, Ломоносовский пр-кт, д. 27, корп.
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …
Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis
Abstract Background and Aims Whereas a beneficial effect of intravenous ferric
carboxymaltose (FCM) on symptoms and exercise capacity among patients with iron …
carboxymaltose (FCM) on symptoms and exercise capacity among patients with iron …
Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial
DR Spahn, F Schoenrath, GH Spahn, B Seifert, P Stein… - The Lancet, 2019 - thelancet.com
Background Anaemia and iron deficiency are frequent in patients scheduled for cardiac
surgery. This study assessed whether immediate preoperative treatment could result in …
surgery. This study assessed whether immediate preoperative treatment could result in …
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
P Ponikowski, BA Kirwan, SD Anker, T McDonagh… - The Lancet, 2020 - thelancet.com
Background Intravenous ferric carboxymaltose has been shown to improve symptoms and
quality of life in patients with chronic heart failure and iron deficiency. We aimed to evaluate …
quality of life in patients with chronic heart failure and iron deficiency. We aimed to evaluate …
[HTML][HTML] Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) …
VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
РЕКОМЕНДАЦИИ, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …
Highlights in heart failure
D Tomasoni, M Adamo, CM Lombardi… - ESC heart …, 2019 - Wiley Online Library
Heart failure (HF) remains a major cause of mortality, morbidity, and poor quality of life. It is
an area of active research. This article is aimed to give an update on recent advances in all …
an area of active research. This article is aimed to give an update on recent advances in all …
[HTML][HTML] Iron deficiency without anaemia: a diagnosis that matters
A Al-Naseem, A Sallam, S Choudhury, J Thachil - Clinical Medicine, 2021 - Elsevier
Iron deficiency anaemia (IDA) currently affects 1.2 billion people and iron deficiency without
anaemia (IDWA) is at least twice as common. IDWA is poorly recognised by clinicians …
anaemia (IDWA) is at least twice as common. IDWA is poorly recognised by clinicians …
The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases
J Lee, DH Hyun - Antioxidants, 2023 - mdpi.com
Iron is essential for life. Many enzymes require iron for appropriate function. However,
dysregulation of intracellular iron homeostasis produces excessive reactive oxygen species …
dysregulation of intracellular iron homeostasis produces excessive reactive oxygen species …